Zydus Cadila Receives Usfda Approval To Market Generic Cancer Drug In Us

Zydus Cadila Receives Usfda Approval To Market Generic Cancer Drug In Us

By, Admin 12 September 2021

The Company Has Received Final Approval From The Us Food And Drug Administration (Usfda) To Market Decitabine For Injection In The Strength Of 50 Mg/Vial Single-Dose Vial.Drug Firm Zydus Cadila On Saturday Said It Has Received Approval From The Us Health Regulator To Market Decitabine Injection, Used To Treat Certain Types Of Cancers, In The American Market.The Company Has Received Final Approval From The Us Food And Drug Administration (Usfda) To Market Decitabine For Injection In The Strength Of 50 Mg/Vial Single-Dose Vial, Zydus Cadila Said In A Statement.Decitabine Is Used To Treat Myelodysplastic Syndromes, Certain Types Of Blood Or Bone Marrow Cancer. The Drug Will Be Manufactured At The Group'S Injectables Manufacturing Facility, Tbe Drug Maker Said.The Zydus Group Now Has 326 Approvals And Has So Far Filed Over 400 Abbreviated New Drug Applications (Andas) Since The Commencement Of The Filing Process In 2003-04, It Added.Also Read: Govt Places Purchase Order For 1 Crore Doses Of Zydus Cadila'S Needle-Free Covid-19 VaccineAlso Read: Zydus Cadila To Supply 1 Crore Doses Of Covid-19 Vaccine Zycov-D To Indian Govt

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!